OBJECTIVE: We demonstrate the feasibility of implementing a referral and management system for cryotherapy-ineligible women in a "screen-and-treat" cervical cancer prevention program targeting HIV-infected women in Zambia. METHODS: We established criteria for patient referral, developed a training program for loop electrosurgical excision procedure (LEEP) providers, and adapted LEEP to a resource-constrained setting. RESULTS: We successfully trained 15 nurses to perform visual inspection with acetic acid (VIA) followed by immediate cryotherapy. Women with positive tests but ineligible for cryotherapy were referred for further evaluation. We trained four Zambian physicians to evaluate referrals, perform punch biopsy, LEEP, and manage intra-operative and post-operative complications. From January 2006 through October 2007, a total of 8823 women (41.5% HIV seropositive) were evaluated by nurses in outlying prevention clinics; of these, 1477 (16.7%) were referred for physician evaluation based on established criteria. Of the 875 (59.2% of 1147 referred) that presented for evaluation, 748 (8.4% of total screened) underwent histologic evaluation in the form of punch biopsy or LEEP. Complications associated with LEEP included anesthesia reaction (n=2) which spontaneously resolved, intra-operative (n=12) and post-operative (n=2) bleeding managed by local measures, and post-operative infection (n=12) managed with antibiotics. CONCLUSION: With adaptations for a resource-constrained environment, we have demonstrated that performing LEEP is feasible and safe, with low rates of complications that can be managed locally. It is important to establish referral and management systems using LEEP-based excisional evaluation for women with cryotherapy-ineligible lesions in VIA-based "screen-and-treat" protocols nested within HIV-care programs in resource-constrained settings.
OBJECTIVE: We demonstrate the feasibility of implementing a referral and management system for cryotherapy-ineligible women in a "screen-and-treat" cervical cancer prevention program targeting HIV-infectedwomen in Zambia. METHODS: We established criteria for patient referral, developed a training program for loop electrosurgical excision procedure (LEEP) providers, and adapted LEEP to a resource-constrained setting. RESULTS: We successfully trained 15 nurses to perform visual inspection with acetic acid (VIA) followed by immediate cryotherapy. Women with positive tests but ineligible for cryotherapy were referred for further evaluation. We trained four Zambian physicians to evaluate referrals, perform punch biopsy, LEEP, and manage intra-operative and post-operative complications. From January 2006 through October 2007, a total of 8823 women (41.5% HIV seropositive) were evaluated by nurses in outlying prevention clinics; of these, 1477 (16.7%) were referred for physician evaluation based on established criteria. Of the 875 (59.2% of 1147 referred) that presented for evaluation, 748 (8.4% of total screened) underwent histologic evaluation in the form of punch biopsy or LEEP. Complications associated with LEEP included anesthesia reaction (n=2) which spontaneously resolved, intra-operative (n=12) and post-operative (n=2) bleeding managed by local measures, and post-operative infection (n=12) managed with antibiotics. CONCLUSION: With adaptations for a resource-constrained environment, we have demonstrated that performing LEEP is feasible and safe, with low rates of complications that can be managed locally. It is important to establish referral and management systems using LEEP-based excisional evaluation for women with cryotherapy-ineligible lesions in VIA-based "screen-and-treat" protocols nested within HIV-care programs in resource-constrained settings.
Authors: C Kietpeerakool; J Srisomboon; P Suprasert; C Phongnarisorn; K Charoenkwan; C Cheewakriangkrai; S Siriaree; C Tantipalakorn; A Pantusart Journal: Int J Gynecol Cancer Date: 2006 May-Jun Impact factor: 3.437
Authors: Lynette Denny; Louise Kuhn; Michelle De Souza; Amy E Pollack; William Dupree; Thomas C Wright Journal: JAMA Date: 2005-11-02 Impact factor: 56.272
Authors: T C Wright; J Koulos; F Schnoll; J Swanbeck; T V Ellerbrock; M A Chiasson; R M Richart Journal: Gynecol Oncol Date: 1994-11 Impact factor: 5.482
Authors: V V Sahasrabuddhe; M H Mwanahamuntu; S H Vermund; W K Huh; M D Lyon; J S A Stringer; G P Parham Journal: Br J Cancer Date: 2007-04-17 Impact factor: 7.640
Authors: Mulindi H Mwanahamuntu; Vikrant V Sahasrabuddhe; Jeffrey S A Stringer; Groesbeck P Parham Journal: Bull World Health Organ Date: 2008-08 Impact factor: 9.408
Authors: Groesbeck P Parham; Mulindi H Mwanahamuntu; Krista S Pfaendler; Vikrant V Sahasrabuddhe; Daniel Myung; Gracilia Mkumba; Sharon Kapambwe; Bianca Mwanza; Carla Chibwesha; Michael L Hicks; Jeffrey S A Stringer Journal: J Low Genit Tract Dis Date: 2010-07 Impact factor: 1.925
Authors: Chemtai Mungo; Craig R Cohen; May Maloba; Elizabeth A Bukusi; Megan J Huchko Journal: Int J Gynaecol Obstet Date: 2013-09-10 Impact factor: 3.561
Authors: Eric Chamot; Sibylle Kristensen; Jeffrey S A Stringer; Mulindi H Mwanahamuntu Journal: BMC Womens Health Date: 2010-04-01 Impact factor: 2.809
Authors: Mulindi H Mwanahamuntu; Vikrant V Sahasrabuddhe; Krista S Pfaendler; Victor Mudenda; Michael L Hicks; Sten H Vermund; Jeffrey S A Stringer; Groesbeck P Parham Journal: AIDS Date: 2009-03-27 Impact factor: 4.177